<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>IBFG. Artículos del Instituto de Biología Funcional y Genómica</title>
<link>http://hdl.handle.net/10366/110571</link>
<description/>
<pubDate>Thu, 23 Apr 2026 19:21:19 GMT</pubDate>
<dc:date>2026-04-23T19:21:19Z</dc:date>
<item>
<title>Refocusing the brain: New approaches in neuroprotection against ischemic injury</title>
<link>http://hdl.handle.net/10366/155415</link>
<description>[EN]A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to review the studies existing to date based in neuroprotection against oxidative stress, which have undoubtedly contributed to clarify the brain endogenous mechanisms, as well as to identify possible therapeutic targets or biomarkers in stroke and other neurological diseases. The efficacy of exogenous administration of neuroprotective compounds has been shown in different studies so far. However, something must be missing to get these treatments successfully applied in the clinical environment. Here, the mechanisms involved in neuronal protection against physiological level of ROS and the main neuroprotective signaling pathways induced by excitotoxic and ischemic stimuli are reviewed. Also, the endogenous ischemic tolerance in terms of brain self-protection mechanisms against subsequent cerebral ischemia is revisited to highlight how the preconditioning has emerged as a powerful tool to understand these phenomena. A better understanding of endogenous defense against exacerbated ROS and metabolism in nervous cells will therefore aid to design pharmacological antioxidants targeted specifically against oxidative damage induced by ischemic injury, but also might be very valuable for translational medicine.
</description>
<pubDate>Fri, 01 Jan 2021 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/155415</guid>
<dc:date>2021-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>The neuronal ischemic tolerance Is conditioned by the Tp53 Arg72Pro polymorphism</title>
<link>http://hdl.handle.net/10366/155312</link>
<description>[EN]Cerebral preconditioning (PC) confers endogenous brain protection after stroke. Ischemic stroke patients with a prior transient ischemic attack (TIA) may potentially be in a preconditioned state. Although PC has been associated with the activation of pro-survival signals, the mechanism by which preconditioning confers neuroprotection is not yet fully clarified. Recently, we have described that PC-mediated neuroprotection against ischemic insult is promoted by p53 destabilization, which is mediated by its main regulator MDM2. Moreover, we have previously described that the human Tp53 Arg72Pro single nucleotide polymorphism (SNP) controls susceptibility to ischemia-induced neuronal apoptosis and governs the functional outcome of patients after stroke. Here, we studied the contribution of the human Tp53 Arg72Pro SNP on PC-induced neuroprotection after ischemia. Our results showed that cortical neurons expressing the Pro72-p53 variant exhibited higher PC-mediated neuroprotection as compared with Arg72-p53 neurons. PC prevented ischemia-induced nuclear and cytosolic p53 stabilization in Pro72-p53 neurons. However, PC failed to prevent mitochondrial p53 stabilization, which occurs in Arg72-p53 neurons after ischemia. Furthermore, PC promoted neuroprotection against ischemia by controlling the p53/active caspase-3 pathway in Pro72-p53, but not in Arg72-p53 neurons. Finally, we found that good prognosis associated to TIA within 1 month prior to ischemic stroke was restricted to patients harboring the Pro72 allele. Our findings demonstrate that the Tp53 Arg72Pro SNP controls PC-promoted neuroprotection against a subsequent ischemic insult by modulating mitochondrial p53 stabilization and then modulates TIA-induced ischemic tolerance.
</description>
<pubDate>Mon, 01 Apr 2019 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/155312</guid>
<dc:date>2019-04-01T00:00:00Z</dc:date>
</item>
<item>
<title>The MDM2-p53 pathway is involved in preconditioning-induced neuronal tolerance to ischemia</title>
<link>http://hdl.handle.net/10366/155255</link>
<description>[EN]Brain preconditioning (PC) refers to a state of transient tolerance against a lethal insult that can be evoked by a prior mild event. It is thought that PC may induce different pathways responsible for neuroprotection, which may involve the attenuation of cell damage pathways, including the apoptotic cell death. In this context, p53 is a stress sensor that accumulates during brain ischemia leading to neuronal death. The murine double minute 2 gene (MDM2), a p53-specific E3 ubiquitin ligase, is the main cellular antagonist of p53, mediating its degradation by the proteasome. Here, we study the role of MDM2-p53 pathway on PC-induced neuroprotection both in cultured neurons (in vitro) and rat brain (in vivo). Our results show that PC increased neuronal MDM2 protein levels, which prevented ischemia-induced p53 stabilization and neuronal death. Indeed, PC attenuated ischemia-induced activation of the p53/PUMA/caspase-3 signaling pathway. Pharmacological inhibition of MDM2-p53 interaction in neurons abrogated PC-induced neuroprotection against ischemia. Finally, the relevance of the MDM2-p53 pathway was confirmed in rat brain using a PC model in vivo. These findings demonstrate the key role of the MDM2-p53 pathway in PC-induced neuroprotection against a subsequent ischemic insult and poses MDM2 as an essential target in ischemic tolerance.
</description>
<pubDate>Thu, 25 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/155255</guid>
<dc:date>2018-01-25T00:00:00Z</dc:date>
</item>
<item>
<title>Single-nucleotide polymorphism 309T&gt;G in the MDM2 promoter determines functional outcome after stroke</title>
<link>http://hdl.handle.net/10366/155254</link>
<description>[EN]Background and Purpose- The E3 ubiquitin ligase MDM2 (murine double minute 2) is the main negative regulator of the p53 protein-a key player in neuronal apoptosis after ischemia. A functional single-nucleotide polymorphism in the human MDM2 gene promoter (rs2279744) regulates MDM2 protein expression. We investigated whether the MDM2 SNP309, by controlling p53-mediated apoptosis, determines functional outcome after stroke. Methods- Primary cortical neurons were subjected to oxygen and glucose deprivation. Mice were subjected to ischemic (transient middle cerebral artery occlusion) or hemorrhagic (collagenase injection) stroke models. Protein and mRNA levels of MDM2 and p53 were measured in both neuronal and brain extracts. The interaction of MDM2 with p53 was disrupted by neuronal treatment with nutlin-3a. siRNA was used to knockdown MDM2 expression. We analyzed the link between the MDM2 SNP309 and functional outcome, measured by the modified Rankin Scale scores, in 2 independent hospital-based stroke cohorts: ischemic stroke cohort (408 patients) and intracerebral hemorrhage cohort (128 patients). Results- Experimental stroke and oxygen and glucose deprivation induced the expression of MDM2 in the brain and neurons, respectively. Moreover, oxygen and glucose deprivation promoted MDM2 binding with p53 in neurons. Disruption of the MDM2-p53 interaction with nutlin-3a, or MDM2 knockdown by siRNA, triggered p53 accumulation, which increased neuronal susceptibility to oxygen and glucose deprivation-induced apoptosis. Finally, we showed that patients harboring the G allele in the MDM2 promoter had higher MDM2 protein levels and showed better functional outcome after stroke than those harboring the T/T genotype. The T/T genotype was also associated with large infarct volume in ischemic stroke and increased lesion volume in patients with intracerebral hemorrhage. Conclusions- Our results reveal a novel role for the MDM2-p53 interaction in neuronal apoptosis after ischemia and show that the MDM2 SNP309 determines the functional outcome of patients after stroke.
</description>
<pubDate>Tue, 04 Sep 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/155254</guid>
<dc:date>2018-09-04T00:00:00Z</dc:date>
</item>
<item>
<title>Preconditioning-activated AKT controls neuronal tolerance to ischemia through the MDM2-p53 pathway</title>
<link>http://hdl.handle.net/10366/155253</link>
<description>EN][One of the most important mechanisms of preconditioning-mediated neuroprotection is the attenuation of cell apoptosis, inducing brain tolerance after a subsequent injurious ischemia. In this context, the antiapoptotic PI3K/AKT signaling pathway plays a key role by regulating cell differentiation and survival. Active AKT is known to increase the expression of murine double minute-2 (MDM2), an E3-ubiquitin ligase that destabilizes p53 to promote the survival of cancer cells. In neurons, we recently showed that the MDM2-p53 interaction is potentiated by pharmacological preconditioning, based on subtoxic stimulation of NMDA glutamate receptor, which prevents ischemia-induced neuronal apoptosis. However, whether this mechanism contributes to the neuronal tolerance during ischemic preconditioning (IPC) is unknown. Here, we show that IPC induced PI3K-mediated phosphorylation of AKT at Ser473, which in turn phosphorylated MDM2 at Ser166. This phosphorylation triggered the nuclear stabilization of MDM2, leading to p53 destabilization, thus preventing neuronal apoptosis upon an ischemic insult. Inhibition of the PI3K/AKT pathway with wortmannin or by AKT silencing induced the accumulation of cytosolic MDM2, abrogating IPC-induced neuroprotection. Thus, IPC enhances the activation of PI3K/AKT signaling pathway and promotes neuronal tolerance by controlling the MDM2-p53 interaction. Our findings provide a new mechanistic pathway involved in IPC-induced neuroprotection via modulation of AKT signaling, suggesting that AKT is a potential therapeutic target against ischemic injury.
</description>
<pubDate>Tue, 06 Jul 2021 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/155253</guid>
<dc:date>2021-07-06T00:00:00Z</dc:date>
</item>
<item>
<title>Functional Impact of the H2A.Z Histone Variant During Meiosis in Saccharomyces cerevisiae</title>
<link>http://hdl.handle.net/10366/146666</link>
<description>[EN]Among the collection of chromatin modifications that influence its function and structure, the substitution of canonical histones by the so-called histone variants is one of the most prominent actions. Since crucial meiotic transactions are modulated by chromatin, here we investigate the functional contribution of the H2A.Z histone variant during both unperturbed meiosis and upon challenging conditions where the meiotic recombination checkpoint is triggered in budding yeast by the absence of the synaptonemal complex component Zip1. We have found that H2A.Z localizes to meiotic chromosomes in an SWR1-dependent manner. Although meiotic recombination is not substantially altered, the htz1 mutant (lacking H2A.Z) shows inefficient meiotic progression, impaired sporulation, and reduced spore viability. These phenotypes are likely accounted for by the misregulation of meiotic gene expression landscape observed in htz1. In the zip1 mutant, the absence of H2A.Z results in a tighter meiotic arrest imposed by the meiotic recombination checkpoint. We have found that Mec1-dependent Hop1-T318 phosphorylation and the ensuing Mek1 activation are not significantly altered in zip1 htz1; however, downstream checkpoint targets, such as the meiosis I-promoting factors Ndt80, Cdc5, and Clb1, are drastically downregulated. The study of the checkpoint response in zip1 htz1 has also allowed us to reveal the existence of an additional function of the Swe1 kinase, independent of CDK inhibitory phosphorylation, which is relevant to restrain meiotic cell cycle progression. In summary, our study shows that the H2A.Z histone variant impacts various aspects of meiotic development adding further insight into the relevance of chromatin dynamics for accurate gametogenesis.
</description>
<pubDate>Mon, 01 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/146666</guid>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Rgf1p (Rho1p GEF) is required for double-strand break repair in fission yeast</title>
<link>http://hdl.handle.net/10366/146281</link>
<description>[EN]Rho GTPases are conserved molecules that control cytoskeletal dynamics. These functions are expedited by Rho GEFs that stimulate the release of GDP to enable GTP binding, thereby allowing Rho proteins to initiate intracellular signaling. How Rho GEFs and Rho GTPases protect cells from DNA damage is unknown. Here, we explore the extreme sensitivity of a deletion mutation in the Rho1p exchange factor Rgf1p to the DNA break/inducing antibiotic phleomycin (Phl). The Rgf1p mutant cells are defective in reentry into the cell cycle following the induction of severe DNA damage. This phenotype correlates with the inability of rgf1Δ cells to efficiently repair fragmented chromosomes after Phl treatment. Consistent with this observation Rad11p (ssDNA binding protein, RPA), Rad52p, Rad54p and Rad51p, which facilitate strand invasion in the process of homology-directed repair (HDR), are permanently stacked in Phl-induced foci in rgf1Δ cells. These phenotypes are phenocopied by genetic inhibition of Rho1p. Our data provide evidence that Rgf1p/Rho1p activity positively controls a repair function that confers resistance against the anti-cancer drug Phl.
</description>
<pubDate>Sun, 01 Jan 2017 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/146281</guid>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Genetic analyses led to the discovery of a super-active mutant of the RNA polymerase I</title>
<link>http://hdl.handle.net/10366/146280</link>
<description>[EN]Most transcriptional activity of exponentially growing cells is carried out by the RNA Polymerase I (Pol I), which produces a ribosomal RNA (rRNA) precursor. In budding yeast, Pol I is a multimeric enzyme with 14 subunits. Among them, Rpa49 forms with Rpa34 a Pol I-specific heterodimer (homologous to PAF53/CAST heterodimer in human Pol I), which might be responsible for the specific functions of the Pol I. Previous studies provided insight in the involvement of Rpa49 in initiation, elongation, docking and releasing of Rrn3, an essential Pol I transcription factor. Here, we took advantage of the spontaneous occurrence of extragenic suppressors of the growth defect of the rpa49 null mutant to better understand the activity of Pol I. Combining genetic approaches, biochemical analysis of rRNA synthesis and investigation of the transcription rate at the individual gene scale, we characterized mutated residues of the Pol I as novel extragenic suppressors of the growth defect caused by the absence of Rpa49. When mapped on the Pol I structure, most of these mutations cluster within the jaw-lobe module, at an interface formed by the lobe in Rpa135 and the jaw made up of regions of Rpa190 and Rpa12. In vivo, the suppressor allele RPA135-F301S restores normal rRNA synthesis and increases Pol I density on rDNA genes when Rpa49 is absent. Growth of the Rpa135-F301S mutant is impaired when combined with exosome mutation rrp6Δ and it massively accumulates pre-rRNA. Moreover, Pol I bearing Rpa135-F301S is a hyper-active RNA polymerase in an in vitro tailed-template assay. We conclude that RNA polymerase I can be engineered to produce more rRNA in vivo and in vitro. We propose that the mutated area undergoes a conformational change that sup.
</description>
<pubDate>Tue, 01 Jan 2019 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/146280</guid>
<dc:date>2019-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Neuronal p38α mediates age‐associated neural stem cell exhaustion and cognitive decline</title>
<link>http://hdl.handle.net/10366/146074</link>
<description>[EN] Neuronal activity regulates cognition and neural stem cell (NSC) function. The molecular pathways limiting neuronal activity during aging remain largely unknown. In this work, we show that p38MAPK activity increases in neurons with age. By using mice expressing p38α-lox and CamkII-Cre alleles (p38α∆-N), we demonstrate that genetic deletion of p38α in neurons suffices to reduce age-associated elevation of p38MAPK activity, neuronal loss and cognitive decline. Moreover, aged p38α∆-N mice present elevated numbers of NSCs in the hippocampus and the subventricular zone. These results reveal novel roles for neuronal p38MAPK in age-associated NSC exhaustion and cognitive decline.
</description>
<pubDate>Thu, 01 Aug 2019 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/146074</guid>
<dc:date>2019-08-01T00:00:00Z</dc:date>
</item>
<item>
<title>The interplay between zinc and iron homeostasis in Aspergillus fumigatus under zinc-replete conditions relies on the iron-mediated regulation of alternative transcription units of zafA and the basal amount of the ZafA zinc-responsiveness transcription factor</title>
<link>http://hdl.handle.net/10366/146072</link>
<description>[EN] Aspergillus fumigatus is a saprophyte fungus that typically grows on organic decaying matter but can also parasitize immunosuppressed hosts. This is explained, in part, by its great ability to take up Zn2+ ions from living tissues, which is induced by the ZafA transcription factor. This study shows that the ZafA-mediated regulation of fungal growth is also influenced by iron availability and that A. fumigatus is well adapted to grow in zinc-limiting and zinc-replete media with Zn:Fe ratios lower in the former than in the latter. Accordingly, this indicates that iron availability appears to be more critical for fungal growth in zinc-replete than in zinc-limiting environments. Interestingly, the cross-regulation of zinc/iron homeostasis under zinc-replete conditions relies on an unprecedented iron-mediated regulation of different zafA transcription units that, along with a limited transcript translation, allows synthesizing the right basal amount of ZafA dependent on iron availability. We posit that this regulatory strategy has evolved in fungi as a mechanism to adjust zinc intake to iron availability under zinc-replete conditions. Thus, fungal growth is enhanced in zinc- and iron-replete media but restricted by reducing zinc intake under iron starvation to prevent the noxious side effects of an intracellular zinc excess during iron deficiency.
</description>
<pubDate>Mon, 01 Apr 2019 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/146072</guid>
<dc:date>2019-04-01T00:00:00Z</dc:date>
</item>
<item>
<title>Yeast Biodiversity in Fermented Doughs and Raw Cereal Matrices and the Study of Technological Traits of Selected Strains Isolated in Spain</title>
<link>http://hdl.handle.net/10366/145528</link>
<description>[EN] Bakers use pure microorganisms and/or traditional sourdoughs as the leavening agent for making bread. The performance of each starter and the substances produced by the microorganisms greatly affect the dough rheology and features of breads. Modern sourdoughs inoculated with selected lactic acid bacteria and yeasts are microbiologically stable, safer than traditional sourdoughs, and easy to use. However, the commercial repertoire of baker’s yeasts is still limited. Therefore, there is a demand for new strains of yeast species, capable of conferring distinctive traits to breads made from a variety of agri-food matrices, in the design of innovative starters. In this context, we report the first comprehensive study on yeasts isolated from a wide range of fermented doughs, cereal flours, and grains of Spain. Nine yeast species were identified from 433 isolates, which were distributed among separate clades. Moreover, phenotypic traits of potential technological relevance were identified in selected yeast strains. Mother doughs (MDs) showed the greatest yeast biodiversity, whereas commercial Saccharomyces starters or related and wild strains often dominated the bakery doughs. A metataxonomic analysis of wheat and tritordeum MDs revealed a greater richness of&#13;
yeast species and percentage variations related to the consistency, flour type, and fermentation time of MDs.
</description>
<pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/145528</guid>
<dc:date>2020-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Letter to the editor:  What about incorporating selenium in the therapeutic regimen of SARS-COV-2?</title>
<link>http://hdl.handle.net/10366/145495</link>
<description>[ES] Carta al editor en la que se expresan las ventajas de utilizar selenio en los tratamientos terapéuticos del SARS-CoV-2.
</description>
<pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/145495</guid>
<dc:date>2020-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Characterization of Actinomycetes Strains Isolated from the Intestinal Tract and Feces of the Larvae of the Longhorn Beetle Cerambyx welensii</title>
<link>http://hdl.handle.net/10366/145234</link>
<description>[EN]Actinomycetes constitute a large group of Gram-positive bacteria present in different habitats.&#13;
One of these habitats involves the association of these bacteria with insects. In this work, we have&#13;
studied twenty-four actinomycetes strains isolated from the intestinal tract and feces from larvae of the&#13;
xylophagous coleopteran Cerambyx welensii and have shown that seventeen strains present hydrolytic&#13;
activity of some of the following substrates: cellulose, hemicellulose, starch and proteins. Fourteen&#13;
of the isolates produce antimicrobial molecules against the Gram-positive bacteria Micrococcus&#13;
luteus. Analysis of seven strains led us to identify the production of a wide number of compounds&#13;
including streptanoate, alpiniamide A, alteramides A and B, coproporphyrin III, deferoxamine,&#13;
demethylenenocardamine, dihydropicromycin, nocardamine, picromycin, surugamides A, B, C,&#13;
D and E, tirandamycins A and B, and valinomycin. A significant number of other compounds,&#13;
whose molecular formulae are not included in the Dictionary of Natural Products (DNP), were also&#13;
present in the extracts analyzed, which opens up the possibility of identifying new active antibiotics.&#13;
Molecular identification of ten of the isolated bacteria determined that six of them belong to the genus&#13;
Streptomyces, two of them are included in the genus Amycolatopsis and two in the genus Nocardiopsis.
</description>
<pubDate>Wed, 01 Jan 2020 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/145234</guid>
<dc:date>2020-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Nucleosomal organization and DNA base composition patterns</title>
<link>http://hdl.handle.net/10366/140753</link>
<description>[EN] Nucleosomes are the basic units of chromatin. They compact the genome inside the nucleus and&#13;
regulate the access of proteins to DNA. In the yeast genome, most nucleosomes occupy welldefined&#13;
positions, which are maintained under many different physiological situations and genetic&#13;
backgrounds. Although several short sequence elements have been described that favor or reduce&#13;
the affinity between histones and DNA, the extent to which the DNA sequence affects nucleosome&#13;
positioning in the genomic context remains unclear. Recent analyses indicate that the base&#13;
composition pattern of mononucleosomal DNA differs among species, and that the same sequence&#13;
elements have a different impact on nucleosome positioning in different genomes despite the high&#13;
level of phylogenetic conservation of histones. These studies have also shown that the DNA&#13;
sequence contributes to nucleosome positioning to the point that it is possible to design synthetic&#13;
DNA molecules capable of generating regular and species-specific nucleosomal patterns in vivo.
</description>
<pubDate>Sun, 01 Jan 2017 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/140753</guid>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Nucleosomal signatures impose nucleosome positioning in coding and noncoding sequences in the genome</title>
<link>http://hdl.handle.net/10366/140729</link>
<description>[EN] In the yeast genome, a large proportion of nucleosomes occupy well-defined and stable positions. While the contribution of&#13;
chromatin remodelers and DNA binding proteins to maintain this organization is well established, the relevance of the DNA&#13;
sequence to nucleosome positioning in the genome remains controversial. Through quantitative analysis of nucleosome positioning,&#13;
we show that sequence changes distort the nucleosomal pattern at the level of individual nucleosomes in three&#13;
species of Schizosaccharomyces and in Saccharomyces cerevisiae. This effect is equally detected in transcribed and nontranscribed&#13;
regions, suggesting the existence of sequence elements that contribute to positioning. To identify such elements, we incorporated&#13;
information from nucleosomal signatures into artificial synthetic DNA molecules and found that they generated&#13;
regular nucleosomal arrays indistinguishable from those of endogenous sequences. Strikingly, this information is speciesspecific&#13;
and can be combined with coding information through the use of synonymous codons such that genes from&#13;
one species can be engineered to adopt the nucleosomal organization of another. These findings open the possibility of&#13;
designing coding and noncoding DNA molecules capable of directing their own nucleosomal organization.
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/140729</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Novel Zinc-Attenuating Compounds as Potent Broad-Spectrum Antifungal Agents withIn VitroandIn VivoEfficacy</title>
<link>http://hdl.handle.net/10366/140728</link>
<description>[EN] An increase in the incidence of rare but hard-to-treat invasive fungal pathogens as well as resistance to the currently available antifungal drugs calls for new broad-spectrum antifungals with a novel mechanism of action. Here we report the identification and characterization of two novel zinc-attenuating compounds, ZAC307 and ZAC989, which exhibit broad-spectrum in vitro antifungal activity and in vivo efficacy in a fungal kidney burden candidiasis model. The compounds were identified serendipitously as part of a drug discovery process aimed at finding novel inhibitors of the fungal plasma membrane proton ATPase Pma1. Based on their structure, we hypothesized that they might act as zinc chelators. Indeed, both fluorescence-based affinity determination and potentiometric assays revealed these compounds, subsequently termed zinc-attenuating compounds (ZACs), to have strong affinity for zinc, and their growth inhibitory effects on Candida albicans and Aspergillus fumigatus could be inactivated by the addition of exogenous zinc to fungal growth media. We determined the ZACs to be fungistatic, with a low propensity for resistance development. Gene expression analysis suggested that the ZACs interfere negatively with the expression of genes encoding the major components of the A. fumigatus zinc uptake system, thus supporting perturbance of zinc homeostasis as the likely mode of action. With demonstrated in vitro and in vivo antifungal activity, low propensity for resistance development, and a novel mode of action, the ZACs represent a promising new class of antifungal compounds, and their advancement in a drug development program is therefore warranted.
</description>
<pubDate>Mon, 01 Jan 2018 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10366/140728</guid>
<dc:date>2018-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
